| Authors: |
Qin Y; Department of Melanoma Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA., Petaccia de Macedo M; Department of Translational Molecular Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA., Reuben A; Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA., Forget MA; Department of Melanoma Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA., Haymaker C; Department of Melanoma Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA., Bernatchez C; Department of Melanoma Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA., Spencer CN; Department of Genomic Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA., Gopalakrishnan V; Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA., Reddy S; Department of Melanoma Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA., Cooper ZA; Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.; Department of Genomic Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA., Fulbright OJ; Department of Melanoma Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA., Ramachandran R; Department of Melanoma Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA., Wahl A; Department of Melanoma Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA., Flores E; Department of Melanoma Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA., Thorsen ST; Department of Melanoma Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA., Tavera RJ; Department of Melanoma Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA., Conrad C; Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA., Williams MD; Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA., Tetzlaff MT; Department of Translational Molecular Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA., Wang WL; Department of Translational Molecular Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA., Gombos DS; Section of Ophthalmology, Department of Head and Neck Surgery and The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA., Esmaeli B; Orbital Oncology and Ophthalmic Plastic Surgery, Department of Plastic Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA., Amaria RN; Department of Melanoma Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA., Hwu P; Department of Melanoma Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA., Wargo JA; Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.; Department of Genomic Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA., Lazar AJ; Department of Translational Molecular Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA., Patel SP; Department of Melanoma Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA. |
